Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Connettivina is a topical pharmaceutical product primarily containing hyaluronic acid sodium salt as its active ingredient. It is used to promote healing and regeneration of the skin in cases of wounds, abrasions, minor burns, skin ulcers, and irritations. The mechanism of action involves hyaluronic acid's ability to maintain tissue hydration and support cellular repair processes. Some formulations (notably "Connettivina Plus") also contain silver sulfadiazine for additional antimicrobial activity. The product is available in various forms including creams, gels, medicated gauzes, and lip balms. It is indicated for both acute and chronic skin injuries with or without risk of infection[2][3][4][5][6][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on connettivina.